BLFS
BIOLIFE SOLUTIONS INCPrice
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $28.1M.
- InstitutionsBEARISH
Q3 2026: 13 added (7 new), 25 trimmed or exited. Largest new: Magnetar Financial $42.5M, Soros Fund Management $26.1M.
- EstimatesRISING
Current-quarter EPS estimate $0.040 → $0.070 over 90 days.
- Short sellersSTEADY
Short interest +3.0% to 4.00M shares. 4.3 days to cover, ≈8.2% of shares.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Invesco Ltd. | TRIM | $48.4M |
| Magnetar Financial LLC | NEW | $42.5M |
| SOROS FUND MANAGEMENT LLC | NEW | $26.1M |
| UBS Group AG | TRIM | $23.3M |
| Qube Research & Technologies Ltd | NEW | $21.3M |
| ROYCE & ASSOCIATES LP | TRIM | $14.4M |
| Alberta Investment Management Corp | NEW | $13.9M |
| AXIOM INVESTORS LLC /DE | NEW | $12.9M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Aug 2026| Date | Firm | Rating |
|---|---|---|
| Aug 10, 2026 | Benchmark DOWNGRADE | Hold |
| Jul 27, 2026 | Stephens & Co. DOWNGRADE | Equal-Weight |
| Jul 23, 2026 | Jefferies DOWNGRADE | Hold |
| Jul 23, 2026 | TD Cowen DOWNGRADE | Hold |
| Jul 22, 2026 | Lake Street DOWNGRADE | Hold |
| Jul 22, 2026 | HC Wainwright & Co. DOWNGRADE | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
DE GREEF RODERICK Chief Executive Officer Oct 6, 2026 | TAX W/H | $14.1M |
DE GREEF RODERICK Chief Executive Officer Oct 6, 2026 | TO ISSUER | 826,454 sh |
DE GREEF RODERICK Chief Executive Officer Oct 6, 2026 | AWARD | 237,460 sh |
DE GREEF RODERICK Chief Executive Officer Oct 6, 2026 | AWARD | 225,670 sh |
Mathew Aby J. EVP & Chief Scientific Officer Oct 6, 2026 | TO ISSUER | 404,608 sh |
Berard Todd Chief Marketing Officer Oct 6, 2026 | TO ISSUER | 194,786 sh |
Ellingson Rachel Director Oct 6, 2026 | TO ISSUER | 57,995 sh |
GOSWAMI JOYDEEP Director Oct 6, 2026 | TO ISSUER | 53,156 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.07 | $0.07–$0.07 | +0.0% | $29.3M |
| Next Q | $0.08 | $0.08–$0.08 | +0.0% | $30.0M |
| Current FY | $0.25 | $0.25–$0.25 | +0.0% | $115.3M |
| Next FY | $0.33 | $0.33–$0.33 | +13.8% | $133.9M |
Short side
FINRA· Sep 30, 2026| Oct 5, 2026 | Info Requested | Not resumed |
SecBot reports
15 filings · 2 bullish · 2 bearish · 11 neutral- NEUTRAL SC 13G/ANov 16, 2026
T. Rowe Price Investment Management filed an amended Schedule 13G disclosing a 2.2% passive stake in BioLife Solutions, holding 1,094,026 shares as of September 30, 2026. This is a decrease from the prior 13.4% stake reported by BlackRock in October 2026, though no prior T. Rowe Price 13G was in…
🔒 Fresh report (last 24h), subscribers only
- BEARISH INST-CLUSTERNov 6, 2026
Seven institutional investors reduced BLFS holdings in Q3 2026, with two near-exits and five…
The selling is broad but small in absolute dollars, suggesting a cautious rebalancing rather than a thesis-driven exit. Monitor next earnings for any fundamental deterioration that could explain the…
- NEUTRAL SC 13G/AOct 27, 2026
BlackRock Inc. filed an amended Schedule 13G disclosing a 13.4% passive stake in BioLife Solutions…
BlackRock's 13.4% passive stake is a large institutional holding but routine for a passive asset manager. Monitor for any future conversion to a 13D (activist) filing, which would signal a change in…
- NEUTRAL 15-12GOct 16, 2026
BioLife Solutions, Inc. filed a Form 15-12G to terminate its SEC registration under Section 12(g)…
The deregistration is a routine post-merger formality. BLFS common stock has been acquired and delisted; monitor Repligen (RGEN) for any integration updates or contingent value rights.
All BLFS filing & press-release reports (15)
- SC 13G/A reportNov 16, 2026
- INST-CLUSTER reportNov 6, 2026
- SC 13G/A reportOct 27, 2026
- 15-12G reportOct 16, 2026
- EFFECT reportOct 13, 2026
- EFFECT reportOct 13, 2026
- 8-K reportOct 6, 2026
- 425 reportSep 30, 2026
- DEFA14A reportSep 30, 2026
- SC 13G reportSep 24, 2026
- DEFM14A reportSep 4, 2026
- 8-K reportJun 3, 2026
- 10-K/A reportApr 28, 2026
- CLUSTER reportMar 3, 2026
- CLUSTER reportMar 3, 2026